Bcl-2 prevents doxorubicin-induced apoptosis of human liver cancer cells

Masahiko Takahashi, Hidetsugu Saito, Kazuhiro Atsukawa, Hirotoshi Ebinuma, Torayuki Okuyama, Hiromasa Ishii

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

We have isolated two stable human bcl-2 transfected cell lines, HCC-T-bcl and PLC-bcl, that were derived from the transfection of two human hepatocellular carcinoma cell lines (HCC-T and PLC/PRF/5, respectively) with a plasmid vector containing recombinant bcl-2 (pCAGGS-bcl).) Cell lines transfected with the plasmid alone (pCAGGS-neo) were also established as controls (HCC-T-neo and PLC-neo). HCC-T-neo and PLC-neo were sensitive to doxorubicin-induced apoptosis, as defined by morphological observation. Although HCC-T-neo expressed endogenous Bcl-2, the sensitivity of HCC-T-neo to doxorubicin-induced cytotoxicity was similar to that of PLC-neo, which does not express endogenous Bcl-2. In contrast, both HCC-T-bcl and PLC-bcl were more resistant to doxorubicin-induced cytotoxicity. Although these bcl-2 transfectants were resistant to the drug-induced apoptosis, Bcl-2 overexpression did not affect doxorubicin-induced growth suppression. These results suggest that the overexpression of Bcl-2 renders human HCC cells resistant to doxorubicin-induced cytotoxicity.

Original languageEnglish
Pages (from-to)192-201
Number of pages10
JournalHepatology Research
Volume25
Issue number2
DOIs
Publication statusPublished - 2003 Feb 1

Fingerprint

Liver Neoplasms
Doxorubicin
Apoptosis
Cell Line
Plasmids
Transfection
Hepatocellular Carcinoma
Observation
Growth
Pharmaceutical Preparations

Keywords

  • Apoptosis
  • Bcl-2
  • Doxorubicin
  • Human hepatoma cell line

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Bcl-2 prevents doxorubicin-induced apoptosis of human liver cancer cells. / Takahashi, Masahiko; Saito, Hidetsugu; Atsukawa, Kazuhiro; Ebinuma, Hirotoshi; Okuyama, Torayuki; Ishii, Hiromasa.

In: Hepatology Research, Vol. 25, No. 2, 01.02.2003, p. 192-201.

Research output: Contribution to journalArticle

Takahashi, M, Saito, H, Atsukawa, K, Ebinuma, H, Okuyama, T & Ishii, H 2003, 'Bcl-2 prevents doxorubicin-induced apoptosis of human liver cancer cells', Hepatology Research, vol. 25, no. 2, pp. 192-201. https://doi.org/10.1016/S1386-6346(02)00244-9
Takahashi, Masahiko ; Saito, Hidetsugu ; Atsukawa, Kazuhiro ; Ebinuma, Hirotoshi ; Okuyama, Torayuki ; Ishii, Hiromasa. / Bcl-2 prevents doxorubicin-induced apoptosis of human liver cancer cells. In: Hepatology Research. 2003 ; Vol. 25, No. 2. pp. 192-201.
@article{634b1defc94340a7bb034e58098f5650,
title = "Bcl-2 prevents doxorubicin-induced apoptosis of human liver cancer cells",
abstract = "We have isolated two stable human bcl-2 transfected cell lines, HCC-T-bcl and PLC-bcl, that were derived from the transfection of two human hepatocellular carcinoma cell lines (HCC-T and PLC/PRF/5, respectively) with a plasmid vector containing recombinant bcl-2 (pCAGGS-bcl).) Cell lines transfected with the plasmid alone (pCAGGS-neo) were also established as controls (HCC-T-neo and PLC-neo). HCC-T-neo and PLC-neo were sensitive to doxorubicin-induced apoptosis, as defined by morphological observation. Although HCC-T-neo expressed endogenous Bcl-2, the sensitivity of HCC-T-neo to doxorubicin-induced cytotoxicity was similar to that of PLC-neo, which does not express endogenous Bcl-2. In contrast, both HCC-T-bcl and PLC-bcl were more resistant to doxorubicin-induced cytotoxicity. Although these bcl-2 transfectants were resistant to the drug-induced apoptosis, Bcl-2 overexpression did not affect doxorubicin-induced growth suppression. These results suggest that the overexpression of Bcl-2 renders human HCC cells resistant to doxorubicin-induced cytotoxicity.",
keywords = "Apoptosis, Bcl-2, Doxorubicin, Human hepatoma cell line",
author = "Masahiko Takahashi and Hidetsugu Saito and Kazuhiro Atsukawa and Hirotoshi Ebinuma and Torayuki Okuyama and Hiromasa Ishii",
year = "2003",
month = "2",
day = "1",
doi = "10.1016/S1386-6346(02)00244-9",
language = "English",
volume = "25",
pages = "192--201",
journal = "Hepatology Research",
issn = "1386-6346",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "2",

}

TY - JOUR

T1 - Bcl-2 prevents doxorubicin-induced apoptosis of human liver cancer cells

AU - Takahashi, Masahiko

AU - Saito, Hidetsugu

AU - Atsukawa, Kazuhiro

AU - Ebinuma, Hirotoshi

AU - Okuyama, Torayuki

AU - Ishii, Hiromasa

PY - 2003/2/1

Y1 - 2003/2/1

N2 - We have isolated two stable human bcl-2 transfected cell lines, HCC-T-bcl and PLC-bcl, that were derived from the transfection of two human hepatocellular carcinoma cell lines (HCC-T and PLC/PRF/5, respectively) with a plasmid vector containing recombinant bcl-2 (pCAGGS-bcl).) Cell lines transfected with the plasmid alone (pCAGGS-neo) were also established as controls (HCC-T-neo and PLC-neo). HCC-T-neo and PLC-neo were sensitive to doxorubicin-induced apoptosis, as defined by morphological observation. Although HCC-T-neo expressed endogenous Bcl-2, the sensitivity of HCC-T-neo to doxorubicin-induced cytotoxicity was similar to that of PLC-neo, which does not express endogenous Bcl-2. In contrast, both HCC-T-bcl and PLC-bcl were more resistant to doxorubicin-induced cytotoxicity. Although these bcl-2 transfectants were resistant to the drug-induced apoptosis, Bcl-2 overexpression did not affect doxorubicin-induced growth suppression. These results suggest that the overexpression of Bcl-2 renders human HCC cells resistant to doxorubicin-induced cytotoxicity.

AB - We have isolated two stable human bcl-2 transfected cell lines, HCC-T-bcl and PLC-bcl, that were derived from the transfection of two human hepatocellular carcinoma cell lines (HCC-T and PLC/PRF/5, respectively) with a plasmid vector containing recombinant bcl-2 (pCAGGS-bcl).) Cell lines transfected with the plasmid alone (pCAGGS-neo) were also established as controls (HCC-T-neo and PLC-neo). HCC-T-neo and PLC-neo were sensitive to doxorubicin-induced apoptosis, as defined by morphological observation. Although HCC-T-neo expressed endogenous Bcl-2, the sensitivity of HCC-T-neo to doxorubicin-induced cytotoxicity was similar to that of PLC-neo, which does not express endogenous Bcl-2. In contrast, both HCC-T-bcl and PLC-bcl were more resistant to doxorubicin-induced cytotoxicity. Although these bcl-2 transfectants were resistant to the drug-induced apoptosis, Bcl-2 overexpression did not affect doxorubicin-induced growth suppression. These results suggest that the overexpression of Bcl-2 renders human HCC cells resistant to doxorubicin-induced cytotoxicity.

KW - Apoptosis

KW - Bcl-2

KW - Doxorubicin

KW - Human hepatoma cell line

UR - http://www.scopus.com/inward/record.url?scp=0037310476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037310476&partnerID=8YFLogxK

U2 - 10.1016/S1386-6346(02)00244-9

DO - 10.1016/S1386-6346(02)00244-9

M3 - Article

AN - SCOPUS:0037310476

VL - 25

SP - 192

EP - 201

JO - Hepatology Research

JF - Hepatology Research

SN - 1386-6346

IS - 2

ER -